Core Laboratories CLB Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Corporate And Other | -$450K-33.5% | -$337K+16.8% | -$405K+51.7% | -$838K-29.9% | |
| Operating Segment Production Enhancement | $178.84M+0.6% | $177.7M+0.7% | $176.45M-3.1% | $182.04M+16.2% | |
| Operating Segment Reservoir Description | $347.68M+0.4% | $346.15M+3.8% | $333.35M+8.3% | $307.69M-1.9% | |
| Other Operating Income Expense Net by Business | |||||
| Corporate And Other | $2.03M— | —— | $27K-97.9% | $1.28M— | |
| Operating Segment Production Enhancement | $284K+152% | -$550K-11,100% | $5K+100% | -$1.41M— | |
| Operating Segment Reservoir Description | $6.05M-47.6% | $11.54M+1,061% | $994K-8.7% | $1.09M— | |
| Operating Income by Business | |||||
| Corporate And Other | $490K+2.3% | $479K-55.8% | $1.08M-52.3% | $2.27M+99.0% | |
| Operating Segment Production Enhancement | $12.06M— | —— | $12.52M-27.5% | $17.27M+13.9% | |
| Operating Segment Reservoir Description | $43.94M-14.6% | $51.47M+25.4% | $41.04M+79.2% | $22.9M-20.9% | |
| Total Assets by Business | |||||
| Corporate And Other | $488.71M+0.1% | $488.22M-1.5% | $495.43M— | —— | |
| Operating Segment Production Enhancement | $580.39M-7.5% | $627.23M-4.6% | $657.55M— | —— | |
| Operating Segment Reservoir Description | $1.29B+2.3% | $1.27B+3.6% | $1.22B— | —— | |
| Cost of Goods Sold by Business | |||||
| Corporate And Other | $924K+264% | -$564K+67.2% | -$1.72M-4.4% | -$1.64M— | |
| Operating Segment Production Enhancement | $147.39M-3.0% | $151.92M+4.6% | $145.19M+0.1% | $145.12M— | |
| Operating Segment Reservoir Description | $269.27M0.0% | $269.17M+4.9% | $256.48M+2.5% | $250.18M— | |
| Segment Expenditure Addition To Long Lived Assets by Business | |||||
| Corporate And Other | $209K-30.1% | $299K— | —— | $577K-65.8% | |
| Operating Segment Production Enhancement | $2.2M+67.1% | $1.32M-27.1% | $1.81M-17.1% | $2.18M-4.4% | |
| Operating Segment Reservoir Description | $12.18M+6.7% | $11.41M+37.3% | $8.31M+11.5% | $7.46M-22.1% | |
| General And Administrative Expense by Business | |||||
| Corporate And Other | $0— | $0— | $0— | $0— | |
| Operating Segment Production Enhancement | $15.77M+10.8% | $14.24M-1.6% | $14.47M+4.4% | $13.85M— | |
| Operating Segment Reservoir Description | $29.66M+16.2% | $25.53M-1.0% | $25.79M+6.3% | $24.26M— | |
| Foreign Currency Transaction Gain Loss Before Tax by Business | |||||
| Corporate And Other | -$181K-291% | $95K+137% | -$257K-236% | $189K— | |
| D&A by Business | |||||
| Corporate And Other | $0— | $0-100% | $1K— | $0-100% | |
| Operating Segment Production Enhancement | $4.12M-4.1% | $4.29M-0.7% | $4.32M-12.8% | $4.95M-13.5% | |
| Operating Segment Reservoir Description | $10.53M-1.2% | $10.66M-7.0% | $11.46M-6.1% | $12.21M+3.5% | |
| Goodwill Acquired by Business | |||||
| Production Enhancement | $0— | —— | —— | —— | |
| Reservoir Description | $6.34M— | —— | —— | —— | |
| Revenue by Geography | |||||
| Non Us | $351.19M+1.8% | $344.95M+4.1% | $331.24M— | —— | |
| US | $175.33M-2.0% | $178.9M+0.2% | $178.55M+7.1% | $166.7M+12.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Core Laboratories break its business down?
- Core Laboratories (CLB) reports revenue by business across 3 parts — Corporate And Other, Operating Segment Production Enhancement and Operating Segment Reservoir Description. Each is extracted from the segment footnotes and tracked over time.
- Where does Core Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Core Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
